A high-throughput screening system targeting the nuclear export pathway via the third nuclear export signal of influenza A virus nucleoprotein

Virus Research

Volumn 217, Issue , 2016, Pages 23-31

  Kakisaka, Michinori ^a   Mano, Takafumi ^a   Aida, Yoko ^a  

^a RIKEN   (Japan)

Author keywords

Compound; HTS; Influenza virus; NES; NP; Nuclear export

Indexed keywords

ANTIVIRUS AGENT; DP 2392E 10; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LEPTOMYCIN B; UNCLASSIFIED DRUG; VIRUS NUCLEOPROTEIN; CORE PROTEIN; NP PROTEIN, INFLUENZA A VIRUS; RNA BINDING PROTEIN;

AEQUOREA; AEQUOREA COERULESCENS; ANIMAL CELL; ANTIVIRAL ACTIVITY; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG IDENTIFICATION; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; INFLUENZA A VIRUS; MDCK CELL LINE; NONHUMAN; NUCLEAR EXPORT SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DOG; DRUG DELIVERY SYSTEM; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; PLASMID; PROCEDURES; VALIDATION STUDY;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; DRUG DELIVERY SYSTEMS; INFLUENZA A VIRUS; MADIN DARBY CANINE KIDNEY CELLS; MICROBIAL SENSITIVITY TESTS; NUCLEAR EXPORT SIGNALS; PLASMIDS; RECOMBINANT FUSION PROTEINS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; VIRAL CORE PROTEINS;

EID: 84960907602     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2016.02.007     Document Type: Review

References (35)

1. Aida Y., Sasaki Y., Hagiwara K. Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein. Antivir. Drugs Asp. Clin. Use Recent Adv. 2012, 99-120.
2. Arranz R., Coloma R., Chichon F.J., Conesa J.J., Carrascosa J.L., Valpuesta J.M., Ortin J., Martin-Benito J. The structure of native influenza virion ribonucleoproteins. Science 2012, 338(6114):1634-1637.
3. Cao S., Liu X., Yu M., Li J., Jia X., Bi Y., Sun L., Gao G.F., Liu W. A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication. J. Virol. 2012, 86(9):4883-4891.
4. Chutiwitoonchai N., Kakisaka M., Yamada K., Aida Y. Comparative analysis of seven viral nuclear export signals (NESs) reveals the crucial role of nuclear export mediated by the third NES consensus sequence of nucleoprotein (NP) in influenza A virus replication. PLoS One 2014, 9(8):e105081.
5. Cianci C., Gerritz S.W., Deminie C., Krystal M. Influenza nucleoprotein: promising target for antiviral chemotherapy. Antivir. Chem. Chemother. 2013, 23(3):77-91.
6. De Clercq E. Antiviral agents active against influenza A viruses. Nat. Rev. Drug Discov. 2006, 5(12):1015-1025.
7. Elton D., Simpson-Holley M., Archer K., Medcalf L., Hallam R., McCauley J., Digard P. Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J. Virol. 2001, 75(1):408-419.
8. Furuta Y., Takahashi K., Kuno-Maekawa M., Sangawa H., Uehara S., Kozaki K., Nomura N., Egawa H., Shiraki K. Mechanism of action of T-705 against influenza virus. Antimicrob. Agents Chemother. 2005, 49(3):981-986.
9. Gerritz S.W., Cianci C., Kim S., Pearce B.C., Deminie C., Discotto L., McAuliffe B., Minassian B.F., Shi S., Zhu S., Zhai W., Pendri A., Li G., Poss M.A., Edavettal S., McDonnell P.A., Lewis H.A., Maskos K., Mortl M., Kiefersauer R., Steinbacher S., Baldwin E.T., Metzler W., Bryson J., Healy M.D., Philip T., Zoeckler M., Schartman R., Sinz M., Leyva-Grado V.H., Hoffmann H.H., Langley D.R., Meanwell N.A., Krystal M. Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(37):15366-15371.
10. Hagiwara K., Kondoh Y., Ueda A., Yamada K., Goto H., Watanabe T., Nakata T., Osada H., Aida Y. Discovery of novel antiviral agents directed against the influenza A virus nucleoprotein using photo-cross-linked chemical arrays. Biochem. Biophys. Res. Commun. 2010, 394(3):721-727.
11. Hao L., Sakurai A., Watanabe T., Sorensen E., Nidom C.A., Newton M.A., Ahlquist P., Kawaoka Y. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008, 454(7206):890-893.
12. Hu Y., Lu S., Song Z., Wang W., Hao P., Li J., Zhang X., Yen H.L., Shi B., Li T., Guan W., Xu L., Liu Y., Wang S., Zhang X., Tian D., Zhu Z., He J., Huang K., Chen H., Zheng L., Li X., Ping J., Kang B., Xi X., Zha L., Li Y., Zhang Z., Peiris M., Yuan Z. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013, 381(9885):2273-2279.
13. Huang S., Chen J., Chen Q., Wang H., Yao Y., Chen J., Chen Z. A second CRM1-dependent nuclear export signal in the influenza A virus NS2 protein contributes to the nuclear export of viral ribonucleoproteins. J. Virol. 2013, 87(2):767-778.
14. Kakisaka M., Sasaki Y., Yamada K., Kondoh Y., Hikono H., Osada H., Tomii K., Saito T., Aida Y. A novel antiviral target structure involved in the RNA binding, dimerization, and nuclear export functions of the influenza A virus nucleoprotein. PLoS Pathog. 2015, 11(7):e1005062.
15. Kao R.Y., Yang D., Lau L.S., Tsui W.H., Hu L., Dai J., Chan M.P., Chan C.M., Wang P., Zheng B.J., Sun J., Huang J.D., Madar J., Chen G., Chen H., Guan Y., Yuen K.Y. Identification of influenza A nucleoprotein as an antiviral target. Nat. Biotechnol. 2010, 28(6):600-605.
16. Konig R., Stertz S., Zhou Y., Inoue A., Hoffmann H.H., Bhattacharyya S., Alamares J.G., Tscherne D.M., Ortigoza M.B., Liang Y., Gao Q., Andrews S.E., Bandyopadhyay S., De Jesus P., Tu B.P., Pache L., Shih C., Orth A., Bonamy G., Miraglia L., Ideker T., Garcia-Sastre A., Young J.A., Palese P., Shaw M.L., Chanda S.K. Human host factors required for influenza virus replication. Nature 2010, 463(7282):813-817.
17. la Cour T., Kiemer L., Molgaard A., Gupta R., Skriver K., Brunak S. Analysis and prediction of leucine-rich nuclear export signals. Protein Eng. Des. Sel. 2004, 17(6):527-536.
18. Li Y., Yamakita Y., Krug R.M. Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(9):4864-4869.
19. Moeller A., Kirchdoerfer R.N., Potter C.S., Carragher B., Wilson I.A. Organization of the influenza virus replication machinery. Science 2012, 338(6114):1631-1634.
20. Mutka S.C., Yang W.Q., Dong S.D., Ward S.L., Craig D.A., Timmermans P.B., Murli S. Identification of nuclear export inhibitors with potent anticancer activity in vivo. Cancer Res. 2009, 69(2):510-517.
21. O'Neill R.E., Talon J., Palese P. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J. 1998, 17(1):288-296.
22. Paterson D., Fodor E. Emerging roles for the influenza A virus nuclear export protein (NEP). PLoS Pathog. 2012, 8(12):e1003019.
23. Poland G.A., Jacobson R.M., Ovsyannikova I.G. Influenza virus resistance to antiviral agents: a plea for rational use. Clin. Infect. Dis. 2009, 48(9):1254-1256.
24. Sasaki Y., Hagiwara K., Kakisaka M., Yamada K., Murakami T., Aida Y. Importin alpha3/Qip1 is involved in multiplication of mutant influenza virus with alanine mutation at amino acid 9 independently of nuclear transport function. PLoS One 2013, 8(1):e55765.
25. Sasaki Y., Kakisaka M., Chutiwitoonchai N., Tajima S., Hikono H., Saito T., Aida Y. Identification of a novel multiple kinase inhibitor with potent antiviral activity against influenza virus by reducing viral polymerase activity. Biochem. Biophys. Res. Commun. 2014, 450(1):49-54.
26. Satterly N., Tsai P.L., van Deursen J., Nussenzveig D.R., Wang Y., Faria P.A., Levay A., Levy D.E., Fontoura B.M. Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(6):1853-1858.
27. Sun Q., Carrasco Y.P., Hu Y., Guo X., Mirzaei H., Macmillan J., Chook Y.M. Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(4):1303-1308.
28. Szucs T.D. Medical economics in the field of influenza-past, present and future. Virus Res. 2004, 103(1-2):25-30.
29. Taubenberger J.K., Kash J.C. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 2010, 7(6):440-451.
30. Watanabe K., Takizawa N., Katoh M., Hoshida K., Kobayashi N., Nagata K. Inhibition of nuclear export of ribonucleoprotein complexes of influenza virus by leptomycin B. Virus Res. 2001, 77(1):31-42.
31. Watanabe K., Noda S., Kobayashi N. Establishment of a new cell line for performing sensitive screening of nuclear export inhibitors. Drug Discov. Ther. 2008, 2(1):7-9.
32. Wen W., Meinkoth J.L., Tsien R.Y., Taylor S.S. Identification of a signal for rapid export of proteins from the nucleus. Cell 1995, 82(3):463-473.
33. Yamada K., Koyama H., Hagiwara K., Ueda A., Sasaki Y., Kanesashi S.N., Ueno R., Nakamura H.K., Kuwata K., Shimizu K., Suzuki M., Aida Y. Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase. Microbes Infect. 2012, 14(9):740-747.
34. Yu M., Liu X., Cao S., Zhao Z., Zhang K., Xie Q., Chen C., Gao S., Bi Y., Sun L., Ye X., Gao G.F., Liu W. Identification and characterization of three novel nuclear export signals in the influenza A virus nucleoprotein. J. Virol. 2012, 86(9):4970-4980.
35. Zhang J.H., Chung T.D., Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999, 4(2):67-73.